The Effect Of Vitamin D Replacement Therapy On Serum Leptin And Follicular Growth Pattern In Women With Resistant Polycystic Ovary
The Effect Of Vitamin D Replacement Therapy On Serum Leptin And Follicular Growth Pattern In Women With Resistant Polycystic Ovary
The study included 100 female diagnosed with polycystic ovary syndrome. They were classified
 into 2 groups: Study group included 50 women will receive 300.000 I.U single dose of Vitamin
 D intramuscular injection (Memphis company) , and in the next menstrual cycle induction done
 by clomiphen citrate 100mg daily for 5 days starting from third day of menstruation and HMG
 single dose on 8th day . Control group included 50 women will receive only clomiphen citrate
 100mg daily for 5 days starting from third day of menstruation and HMG single dose on 8th
 day. Serum 25 hydroxy Vitamin D3, Serum Leptin and FSH will be done to all women before and
 after intervention.
The study included 100 female diagnosed with polycystic ovary syndrome diagnosed by by
 presence of 2 out of 3 criteria (according to ESHRE/ASRM in Rotterdam in 2003):
 oligoovulation and/or an ovulation , excess androgen activity (clinical or biochemical) and
 polycystic ovaries (by pelvic ultrasound "vaginal route").They were classified into 2 groups:
 Study group included 50 women will receive 300.000 I.U single dose of Vitamin D intramuscular
 injection (Memphis company) , and in the next menstrual cycle induction done by clomiphen
 citrate 100mg daily for 5 days starting from third day of menstruation and HMG single dose on
 8th day . Control group included 50 women will receive only clomiphen citrate 100mg daily for
 5 days starting from third day of menstruation and HMG single dose on 8th day. Serum 25
 hydroxy Vitamin D3, Serum Leptin and FSH will be done to all women before and after
 intervention.
Inclusion Criteria:

 1- BMI: more than 25.0 kg/m2

 2- PCO was diagnosed by presence of 2 out of 3 criteria (according to ESHRE/ASRM in
 Rotterdam in 2003)

 1. oligoovulation and/or an ovulation

 2. excess androgen activity (clinical or biochemical)

 3. polycystic ovaries (by pelvic ultrasound "vaginal route")

 3- Anovulatory patient resistant to induction with clomiphene citrate alone

 Exclusion Criteria:

 -1) BMI: more than 35.0 kg/m2

 2) Infertile women due to any factor other than PCO